Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions
Status:
NOT_YET_RECRUITING
Trial end date:
2024-09-20
Target enrollment:
Participant gender:
Summary
Objectives:
To determine and compare the rate and extent of absorption of a test formulation with that of a reference innovator formulation when given as equal labeled dose in healthy subjects under fasting conditions
Study Design:
An open label, randomized, two-treatment, four-period, two-sequence, replicate crossover bioequivalence study in healthy Thai volunteers under fasting conditions with at least 7 days washout period between the administrations of investigational products of each period